Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

9.72
Delayed Data
As of Jul 01
 +0.38 / +4.07%
Today’s Change
7.12
Today|||52-Week Range
17.51
-3.28%
Year-to-Date
Transition (TTHI) Stock Up on News of Acquisition by Opko
Jul 01 / Zacks.com - Paid Partner Content
Is Opko Health a Buy Now That Rayaldee Is Approved?
Jun 21 / MotleyFool.com - Paid Partner Content
Opko Health Sets Its Sights on Diabetes
Jul 01 / MotleyFool.com - Paid Partner Content
Why Sprint, Energy Transfer Equity, and Opko Health Jumped Today
Jun 21 / MotleyFool.com - Paid Partner Content
Opko Is a Buying Opportunity After FDA's Approval of Kidney Drug
Jun 30 / TheStreet.com - Paid Partner Content
Here's Why Opko Health (OPK) Stock Is Gaining Today
Jun 21 / Zacks.com - Paid Partner Content
Opko Health Inc (OPK) CEO & Chairman, 10% Owner Phillip Frost Bought $169,200 of Sto...
Jun 28 / GuruFocus News - Paid Partner Content
Company News for June 21, 2016
Jun 21 / Zacks.com - Paid Partner Content
Opko Health (OPK) Catches Eye: Stock Adds 5.6% in Session
Jun 22 / Zacks.com - Paid Partner Content